The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Engineered Exosomes With Ischemic Myocardium‐Targeting Peptide for Targeted Therapy in Myocardial Infarction
Open accessAbstract
Background: Exosomes are membranous vesicles generated by almost all cells. Recent studies demonstrated that mesenchymal stem cell–derived exosomes possessed many effects, including antiapoptosis, anti‐inflammatory effects, stimulation of angiogenesis, anticardiac remodeling, and recovery of cardiac function on cardiovascular diseases. However, targeting of exosomes to recipient cells precisely in vivo still remains a problem. Ligand fragments or homing peptides discovered by phage display and in vivo biopanning methods fused to the enriched molecules on the external part of exosomes have been exploited to improve the ability of exosomes to target specific tissues or organs carrying cognate receptors. Herein, we briefly elucidated how to improve targeting ability of exosomes to ischemic myocardium. Methods and Results: We used technology of molecular cloning and lentivirus packaging to engineer exosomal enriched membrane protein (Lamp2b) fused with ischemic myocardium‐targeting peptide CSTSMLKAC (IMTP). In vitro results showed that IMTP‐exosomes could be internalized by hypoxia‐injured H9C2 cells more efficiently than blank‐exosomes. Compared with blank‐exosomes, IMTP‐exosomes were observed to be increasingly accumulated in ischemic heart area ( P <0.05). Meanwhile, attenuated inflammation and apoptosis, reduced fibrosis, enhanced vasculogenesis, and cardiac function were detected by mesenchymal stem cell–derived IMTP‐exosome treatment in ischemic heart area. Conclusions: Our research concludes that exosomes engineered by IMTP can specially target ischemic myocardium, and mesenchymal stem cell–derived IMTP‐exosomes exert enhanced therapeutic effects on acute myocardial infarction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930 · cited 1×
“However, only a few studies on tumor or nervous system exploited engineered exosomes for targeted disease therapy.(22,23) Recently, a new peptide sequence, CSTSMLKAC, that can preferentially target to ischemic region of the heart has been discovered via in vivo phage display technique.”
BackgroundSmith, G. P. (1985) · Science · doi:10.1126/science.4001944 · Cited by 4,143
Membrane vesicles as conveyors of immune responses
Théry, C., Ostrowski, M., & Segura, E. (2009) · Nature Reviews Immunology · doi:10.1038/nri2567 · Cited by 3,882
Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart
Toma, C., Pittenger, M. F., Cahill, K. S., Byrne, B. J., & Kessler, P. D. (2002) · Circulation · doi:10.1161/hc0102.101442 · Cited by 2,234
Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury
Lai, R. C., Arslan, F., Lee, M. M., Sze, N. S. K., Choo, A., Chen, T. S., Salto-Tellez, M., Timmers, L., Lee, C. N., El Oakley, R. M., et al. (2010) · Stem Cell Research · doi:10.1016/j.scr.2009.12.003 · Cited by 2,215
Tian, Y., Li, S., Song, J., Ji, T., Zhu, M., Anderson, G. J., Wei, J., & Nie, G. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.083 · Cited by 1,801
Gnecchi, M., He, H., Liang, O. D., Melo, L. G., Morello, F., Mu, H., Noiseux, N., Zhang, L., Pratt, R. E., Ingwall, J. S., et al. (2005) · Nature Medicine · doi:10.1038/nm0405-367 · Cited by 1,677
Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells
Ohno, S.-I., Takanashi, M., Sudo, K., Ueda, S., Ishikawa, A., Matsuyama, N., Fujita, K., Mizutani, T., Ohgi, T., Ochiya, T., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2012.180 · Cited by 1,666
Théry, C., Boussac, M., Véron, P., Ricciardi-Castagnoli, P., Raposo, G., Garin, J., & Amigorena, S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7309 · Cited by 1,563
Hare, J. M., Traverse, J. H., Henry, T. D., Dib, N., Strumpf, R. K., Schulman, S. P., Gerstenblith, G., DeMaria, A. N., Denktas, A. E., Gammon, R. S., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.06.055 · Cited by 1,350
Hare, J. M., Fishman, J. E., Gerstenblith, G., DiFede Velazquez, D. L., Zambrano, J. P., Suncion, V. Y., Tracy, M., Ghersin, E., Johnston, P. V., Brinker, J. A., et al. (2012) · JAMA · doi:10.1001/jama.2012.25321 · Cited by 1,192
Chen, S.-L., Fang, W.-W., Ye, F., Liu, Y.-H., Qian, J., Shan, S.-J., Zhang, J.-J., Chunhua, R. Z., Liao, L.-M., Lin, S., et al. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.03.034 · Cited by 1,191
Self-citationGnecchi, M., He, H., Noiseux, N., Liang, O. D., Zhang, L., Morello, F., Mu, H., Melo, L. G., Pratt, R. E., Ingwall, J. S., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5211com · Cited by 1,157
Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Girard, O. M., Hanahan, D., Mattrey, R. F., & Ruoslahti, E. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.10.013 · Cited by 1,136
Arslan, F., Lai, R. C., Smeets, M. B., Akeroyd, L., Choo, A., Aguor, E. N. E., Timmers, L., van Rijen, H. V., Doevendans, P. A., Pasterkamp, G., et al. (2013) · Stem Cell Research · doi:10.1016/j.scr.2013.01.002 · Cited by 1,107
Amado, L. C., Saliaris, A. P., Schuleri, K. H., St. John, M., Xie, J.-S., Cattaneo, S., Durand, D. J., Fitton, T., Kuang, J. Q., Stewart, G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504388102 · Cited by 1,073
Shake, J. G., Gruber, P. J., Baumgartner, W. A., Senechal, G., Meyers, J., Redmond, J. M., Pittenger, M. F., & Martin, B. J. (2002) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(02)03517-8 · Cited by 901
Bian, S., Zhang, L., Duan, L., Wang, X., Min, Y., & Yu, H. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1110-5 · Cited by 710
Self-citationMirotsou, M., Zhang, Z., Deb, A., Zhang, L., Gnecchi, M., Noiseux, N., Mu, H., Pachori, A., & Dzau, V. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610024104 · Cited by 545
Exosomes for targeted siRNA delivery across biological barriers
EL Andaloussi, S., Lakhal, S., Mäger, I., & Wood, M. J. A. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.008 · Cited by 539
Systemic exosomal siRNA delivery reduced alpha‐synuclein aggregates in brains of transgenic mice
Cooper, J. M., Wiklander, P. B. O., Nordin, J. Z., Al‐Shawi, R., Wood, M. J., Vithlani, M., Schapira, A. H. V., Simons, J. P., El‐Andaloussi, S., & Alvarez‐Erviti, L. (2014) · Movement Disorders · doi:10.1002/mds.25978 · Cited by 507
Cardiopoietic Stem Cell Therapy in Heart Failure
Bartunek, J., Behfar, A., Dolatabadi, D., Vanderheyden, M., Ostojic, M., Dens, J., El Nakadi, B., Banovic, M., Beleslin, B., Vrolix, M., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.071 · Cited by 493
Feng, Y., Huang, W., Wani, M., Yu, X., & Ashraf, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088685 · Cited by 477
Teng, X., Chen, L., Chen, W., Yang, J., Yang, Z., & Shen, Z. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000438594 · Cited by 470
Self-citationTargeting regenerative exosomes to myocardial infarction using cardiac homing peptide
Vandergriff, A., Huang, K., Shen, D., Hu, S., Hensley, M. T., Caranasos, T. G., Qian, L., & Cheng, K. (2018) · Theranostics · doi:10.7150/thno.20524 · Cited by 406
Microvesicles and exosomes: Opportunities for cell-derived membrane vesicles in drug delivery
van Dommelen, S. M., Vader, P., Lakhal, S., Kooijmans, S. A. A., van Solinge, W. W., Wood, M. J. A., & Schiffelers, R. M. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.11.021 · Cited by 398
Phage display-derived peptides as therapeutic alternatives to antibodies
Ladner, R. C., Sato, A. K., Gorzelany, J., & de Souza, M. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03104-6 · Cited by 301
Pathologic function and therapeutic potential of exosomes in cardiovascular disease
Ailawadi, S., Wang, X., Gu, H., & Fan, G.-C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.10.008 · Cited by 260
Self-citationAutologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy
Schuleri, K. H., Feigenbaum, G. S., Centola, M., Weiss, E. S., Zimmet, J. M., Turney, J., Kellner, J., Zviman, M. M., Hatzistergos, K. E., Detrick, B., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp265 · Cited by 253
Zhang, Z., Yang, J., Yan, W., Li, Y., Shen, Z., & Asahara, T. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002856 · Cited by 222
Self-citationBarile, L., Cervio, E., Lionetti, V., Milano, G., Ciullo, A., Biemmi, V., Bolis, S., Altomare, C., Matteucci, M., Di Silvestre, D., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy055 · Cited by 222
Perin, E. C., Silva, G. V., Henry, T. D., Cabreira-Hansen, M. G., Moore, W. H., Coulter, S. A., Herlihy, J. P., Fernandes, M. R., Cheong, B. Y. C., Flamm, S. D., et al. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.01.028 · Cited by 181
Lee, J.-W., Lee, S.-H., Youn, Y.-J., Ahn, M.-S., Kim, J.-Y., Yoo, B.-S., Yoon, J., Kwon, W., Hong, I.-S., Lee, K., et al. (2014) · Journal of Korean Medical Science · doi:10.3346/jkms.2014.29.1.23 · Cited by 179
Identification of targeting peptides for ischemic myocardium by in vivo phage display
Kanki, S., Jaalouk, D. E., Lee, S., Yu, A. Y. C., Gannon, J., & Lee, R. T. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.02.003 · Cited by 176
Homing peptides as targeted delivery vehicles
Laakkonen, P., & Vuorinen, K. (2010) · Integrative Biology · doi:10.1039/c0ib00013b · Cited by 144
Davidson, S. M., Riquelme, J. A., Takov, K., Vicencio, J. M., Boi-Doku, C., Khoo, V. M., Doreth, C., Radenković, D., Lavandero, S., & Yellon, D. M. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13302 · Cited by 110
Hong, H.-Y., Lee, H. Y., Kwak, W., Yoo, J., Na, M., So, I. S., Kwon, T., Park, H., Huh, S., Oh, G. T., et al. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00189.x · Cited by 96
Ko, Y. T., Hartner, W. C., Kale, A. A., & Torchilin, V. P. (2008) · Gene Therapy · doi:10.1038/gt.2008.135 · Cited by 93
Fischer, A. H., Jacobson, K. A., Rose, J., & Zeller, R. (2008) · Cold Spring Harbor Protocols · doi:10.1101/pdb.prot4991 · Cited by 85
Molecular targeting of atherosclerotic plaques by a stabilin-2-specific peptide ligand
Lee, G. Y., Kim, J.-H., Oh, G. T., Lee, B.-H., Kwon, I. C., & Kim, I. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.010 · Cited by 83
Targeted Gene Delivery to Ischemic Myocardium by Homing Peptide-Guided Polymeric Carrier
Won, Y.-W., McGinn, A. N., Lee, M., Bull, D. A., & Kim, S. W. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300500y · Cited by 62
Toba, M., Alzoubi, A., O’Neill, K., Abe, K., Urakami, T., Komatsu, M., Alvarez, D. F., Järvinen, T. A. H., Mann, D., Ruoslahti, E. I., et al. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.10.008 · Cited by 57
Prohibitin protects against hypoxia-induced H9c2 cardiomyocyte cell death
Muraguchi, T., Kawawa, A., & Kubota, S. (2010) · Biomedical Research · doi:10.2220/biomedres.31.113 · Cited by 43
Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration
Blom, J. N., Lu, X., Arnold, P., & Feng, Q. (2016) · Journal of Visualized Experiments · doi:10.3791/54100 · Cited by 40
Thapa, N., Hong, H.-Y., Purushotham, S., Kim, I., Yoo, J., Rhee, K., Oh, G. T., Kwon, I. C., & Lee, B.-H. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.07.013 · Cited by 26
Cited by
Engineering exosomes for targeted drug delivery
Liang, Y., Duan, L., Lu, J., & Xia, J. (2021) · Theranostics · doi:10.7150/thno.52570 · Cited by 1,547
“IMPT exosomes specifically localized to the ischemic myocardium area and exerted cardioprotective effects in acute myocardial infarction [58].”
BackgroundMesenchymal Stem Cell-Derived Exosomes: Applications in Regenerative Medicine
Hade, M. D., Suire, C. N., & Suo, Z. (2021) · Cells · doi:10.3390/cells10081959 · Cited by 607
Salunkhe, S., Dheeraj, Basak, M., Chitkara, D., & Mittal, A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.042 · Cited by 497
Native and bioengineered extracellular vesicles for cardiovascular therapeutics
de Abreu, R. C., Fernandes, H., da Costa Martins, P. A., Sahoo, S., Emanueli, C., & Ferreira, L. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0389-5 · Cited by 493
Engineered Extracellular Vesicles for Cancer Therapy
Zhang, X., Zhang, H., Gu, J., Zhang, J., Shi, H., Qian, H., Wang, D., Xu, W., Pan, J., & Santos, H. A. (2021) · Advanced Materials · doi:10.1002/adma.202005709 · Cited by 428
Metadata
- Authors
- Wang, X., Chen, Y., Zhao, Z., Meng, Q., Yu, Y., Sun, J., Yang, Z., Chen, Y., Li, J., Ma, T., Liu, H., Li, Z., Yang, J., & Shen, Z.
- Venue
- Journal of the American Heart Association
- Published
- 2018-08-07
- Volume
- 7
- Issue
- 15
- Pages
- e008737-e008737
- ISSN
- 2047-9980 (ISSN-L)
- OpenAlex
- W2890366947
- Cited by
- 422
- References
- 45
- FWCI
- 8.48
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.